‘“What’s the point of a TRIPS waiver?” A reply’

“On July 13th, a group of intellectual property academics and experts, including the authors, published an open letter to the governments of UK, Australia, Brazil, Japan, Norway, Switzerland and the EU. We hope the letter can move the debate amongst academics beyond ‘for’ and ‘against’ arguments towards engagement on how to make any suspension of rules under the TRIPS agreement work to enable increases in output of vaccines and other medical technologies …” (more)

[Murali Neelakantan and Siva Thambisetty, The IPKat, 14 July]

First posted 2021-07-15 08:00:28

Leave a Reply